Reviva Pharmaceuticals Holdings, Inc. (RVPH) Misses Q2 EPS by 27c
Tweet
Share
E-mailGet Alerts RVPH Hot Sheet
Join SI Premium – FREE
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q2 EPS of ($0.55), $0.27 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler sees Google TPU sales hitting $104BN by 2028
- Portland General Electric halts holding company restructuring plan
- PB Fintech Limited (POLICYBZ:IN) PT Lowered to INR1,425 at Investec
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
